Notable Analyst Upgrades and Downgrades (NYSE: CPE) (TSXV: TNG)

Published:

The following stocks were upgraded/downgraded on May 12, 2014
Company Name Exchange Ticker Last Price Total Analyst Coverage Upgrade/
Downgrade
Analyst Name Rating Company Target Price Upside/
Downside (%)
TransGaming Inc TSXV TNG 0.15 2 Initiate with speculative buy Damian Wojcichowsky Jacob Securities Inc 0.70 366.7%
Spartan Energy Corp TSXV SPE 3.89 9 Initiate with outperform Ray Kwan Macquarie 5.50 41.4%
Romarco Minerals Inc TSX R 0.77 6 Initiate with buy Michael Parkin Desjardins Securities 1.00 29.9%
TeraGo Inc TSX TGO 5.30 8 Downgrade to hold from buy Dvai Ghose Canaccord Genuity Corp 5.50 3.8%
Morguard Real Estate Investment Trust TSX MRT-U 17.00 6 Downgrade to hold from buy Nelson Mah Laurentian Bank Securities 18.25 7.4%

Jacob Securities Inc initiated coverage on TransGaming Inc (TSXV: TNG), a developer of software portability solutions that facilitate the deployment of games to multiple platforms, with speculative buy assigning a 12-month price target of C$0.70, an upside of 366.7% from current levels.

Macquarie initiated coverage on Spartan Energy Corp (TSXV: SPE), engaged in the exploration for and production of crude oil and natural gas in Canada, with outperform assigning a 12-month price target of C$5.50, an upside of 41.4% from current levels.

Desjardins Securities initiated coverage on Romarco Minerals Inc (TSX: R), an exploration and development stage mining company engaged in the acquisition, exploration and development of precious metals mineral properties, with buy assigning a 12-month price target of C$1.00, an upside of 29.9% from current levels.

Canaccord Genuity Corp downgraded TeraGo Inc (TSX: TGO), a wireless broadband communications service provider to businesses in Canada, to hold from buy, reducing the price target to C$5.50 from C$7.00, an upside of 3.8% from current levels.

Morguard Real Estate Investment Trust (TSX: MRT-U), an unincorporated close-ended real estate investment trust that accumulates a portfolio of real estate assets, and then deliver the benefits of such real estate ownership to unitholders, was downgraded at Laurentian Bank Securities to hold from buy, maintaining the price target at C$18.25, an upside of 7.4% from current levels.

The following stocks were upgraded/downgraded on May 12, 2014
Company Name Exchange Ticker Last Price Total Analyst
Coverage
Upgrade/
Downgrade
Analyst Name Rating Company Target Price Upside/
Downside (%)
Callon Petroleum Co NYSE CPE 10.17 13 Upgrade to outperform from market perform Jeff Grampp Northland Securities Inc 12.00 18.0%
Sterling Construction Co Inc NASDAQ STRL 9.09 5 Upgrade to buy from neutral John B Rogers D.A. Davidson & Co 12.00 32.0%
Tarena International Inc NASDAQ TEDU 8.27 4 Initiate with outperform Dick Wei Credit Suisse 13.00 57.2%
Great Plains Energy Inc NYSE GXP 25.59 15 Downgrade to neutral from buy Brian J Russo Ladenburg Thalmann & Co 27.50 7.5%
Echo Therapeutics Inc NASDAQ ECTE 2.07 2 Downgrade to hold from buy Ben C Haynor Feltl & Company 2.00 -3.4%

Northland Securities Inc upgraded Callon Petroleum Co (NYSE: CPE), an independent oil and natural gas company focused on growing production and reserves from its oil-weighted multi-play assets in the Permian Basin, to outperform from market perform, raising the price target to $12.00 from $7.00, an upside of 18.0% from current levels.

Sterling Construction Co Inc (NASDAQ: STRL), a heavy civil construction company that specializes in the building, reconstruction and repair of transportation and water infrastructure, was upgraded at D.A. Davidson & Co, to buy from neutral, raising the price target to $12.00 from $8.00, an upside of 32.0% from current levels.

Credit Suisse initiated coverage on Tarena International Inc (NASDAQ: TEDU), a provider of professional education services in China, with outperform assigning a 12-month price target of $13.00, an upside of 57.2% from current levels.

Ladenburg Thalmann & Co downgraded Great Plains Energy Inc (NYSE: GXP), a public utility holding company, to neutral from buy, maintaining the price target at $27.50, an upside of 7.5% from current levels.

Echo Therapeutics Inc (NASDAQ: ECTE), a transdermal medical device company focused on developing Prelude SkinPrep System as a technology to allow for painless and skin permeation that enable both analyte extraction and needle-free drug delivery, was downgraded at Feltl & Company to hold from buy, reducing the price target to $2.00 from $8.00, a downside of 3.4% from current levels.

Related articles

Recent articles